This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 26 Oct 2013  |  South Asia, Middle East & North Africa

    Analysis of the LED Lighting Market in the GCC

    Energy Efficient and Cost Effective Technology Resolves Energy Issues for a Greener Environment

    There has been a swift flow of infrastructure investments in the Middle East region, especially in Gulf Cooperation Council (GCC) countries such as KSA and Qatar due to rising population and the upcoming FIFA World Cup in 2022. Government legislations mandating the usage of energy efficient lighting in this region and growing environmental concern ...

    $4,950.00
  2. 25 Oct 2013  |  Africa

    Analysis of the Nigerian Patient Monitor Market

    Urbanisation is the Key Market Growth Driver

    This research service provides an analysis of patient monitors within Nigeria, both in the public sector and private sector markets during the period 2012 to 2019. This research service was compiled using primary and secondary research as the principle methods of data gathering. The patient monitor market is segmented into 3 main product segments â...

    $4,950.00
  3. 24 Oct 2013  |  Asia Pacific

    Competitive Analysis of the Global Opioid Therapeutics Market

    Opportunities Exist for Tamper-resistant Formulations

    The research service presents an overview and analysis of the Asia-Pacific (APAC) contract research organisation (CRO) market and provides revenue forecasts by phase and therapeutic type. It discusses the major issues and challenges, unmet needs, and emerging trends in the market and covers the complete life cycle of the CRO industry, from pre-cli...

    $4,950.00
  4. 17 Oct 2013  |  North America

    US Market for General Wellness and Early Intervention Technologies

    Lowering Employer Costs and Improving Health with Proactive Services

    Wellness has emerged as a fairly umbrella term within the last 5 years. Factors for this include changing attitudes to control health cost by moving from defined benefit to defined contribution structures, and technology tools and transparencies that are shifting capitation from providers to consumers through increased consumer participation and re...

    $4,950.00
  5. 15 Oct 2013  |  Global

    A Product and Pipeline Analysis of the Latin American HIV, Chagas, Dengue, and Influenza H1N1 Therapeutics Markets

    High Incidence of Infectious Diseases Persists, While Treatment Options Remain Scarce

    Latin America presents many opportunities for the infectious diseases market. This market insight offers an overview of the human immunodeficiency virus (HIV), Chagas, dengue, and influenza H1N1 therapeutics markets in Latin America. General market trends are covered, and a competitive landscape, which highlights current drugs on the market as well...

    $3,950.00
  6. 08 Oct 2013  |  Global

    Global Next Generation Sequencing Informatics Market

    Informatics Vendors Flock to Growth in Sequencing Adoption

    More than 100 companies participate in the global next generation sequencing (NGS) informatics market. This research service evaluates the market from 2012 to 2018. The research covers key market drivers and restraints, analysis of the changing competitive landscape, revenue forecasts, and the important trends that affect market growth. Also includ...

    $4,950.00
  7. Given the importance of the changes from PPACA and the creation of the health insurance marketplaces, we are providing our online Frost.com blog on HIX in collected form for the month of September for ease of use by our subscription clients. This discussion is brought to you by our Connected Health research program. Please also follow our blog, par...

    $450.00
  8. 01 Oct 2013  |  North America

    Health Insurance Marketplace Readiness

    Beyond the Politics and Challenge of Implementation

    Beginning October 1, American citizens who do not have health insurance will be eligible to purchase standardized insurance coverage using the new health insurance marketplaces, formally referred to as health insurance exchanges (HIX). This offering will be administered either by their state, federal government, or a combination of both. CMS has re...

    $1,500.00
  9. This issue of Vital Signs, released on September 30, 2013, provides a market overview and drug pipeline analysis of Type 2 diabetes therapeutics. Additionally, a company spotlight is provided for Trovagene in San Diego, CA. The company has a proprietary transrenal nucleic acid platform with the potential to deliver superior molecular diagnostics i...

    $450.00
  10. This issue of Vital Signs, released on September 30, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Pharma/Biotech, In Vitro Diagnostics, Advanced Medical Technology and Connected Health.

    $450.00